• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

AstraZeneca plc

AstraZeneca vaccine recipients in U.K. will wait up to 12 weeks for second dose

December 31, 2020 By Brian Buntz

An inexpensive COVID-19 vaccine from AstraZeneca (LON:AZN) — now authorized in the U.K. — could go on to become the most widely used in the world. It is inexpensive and easy to produce.  But a major hurdle that could slow its rollout in the U.K. after yesterday’s approval is the question of how to best […]

Filed Under: Featured, Pharmaceutical, Regulatory/Compliance Tagged With: AstraZeneca plc, coronavirus, COVID-19, COVID-19 vaccine, Medicines and Healthcare Products Regulatory Agency, Oxford University, United Kingdom

Why AstraZeneca and Sinovac’s COVID-19 vaccines have similar data challenges

December 28, 2020 By Brian Buntz

A vaccine jointly developed by Oxford University and AstraZeneca (LON:AZN) is on the cusp of authorization in the U.K., according to media reports. Meanwhile, health officials in Turkey and Brazil have indicated that a vaccine from the Chinese firm Sinovac is safe and effective. But one factor that could slow the deployment of both vaccines globally is […]

Filed Under: Clinical Trials, Pharmaceutical Tagged With: AstraZeneca plc, coronavirus, COVID-19, COVID-19 vaccine, SinoVac

MedTech 100 roundup: Industry peaks again after new vaccine authorization

December 21, 2020 By Sean Whooley

Recent news in the industry continues to drive its stocks forward, with COVID-19 vaccine developments driving further medtech growth last week. The FDA granted Moderna emergency use authorization for its vaccine candidate on Friday and its rollout to the U.S. is beginning today. Moderna’s vaccine joins the one made by Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX), which […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Mergers & Acquisitions, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: AstraZeneca plc, becton dickinson, Boston Scientific, coronavirus, COVID-19, COVID-19 vaccine, Federal Trade Commission (FTC), Johnson and Johnson, MedTech 100 Index, Philips, Stryker, Wright Medical

AstraZeneca to acquire Alexion for $39B

December 14, 2020 By Sean Whooley

AstraZeneca (NYSE:AZN) announced that it entered into a definitive agreement to acquire Alexion Pharmaceuticals (NSDQ:ALXN), expanding its presence in the rare-disease and immunology drugs space. The acquisition price for Boston-based Alexion is set to total approximately $39 billion, or $175 per share, according to a news release. Get the full story at our sister site, Drug Discovery […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Mergers & Acquisitions, Pharmaceutical, Wall Street Beat Tagged With: alexionpharmaceuticals, AstraZeneca plc

MedTech 100 roundup: Medtech stocks stagnant over holidays

November 30, 2020 By Sean Whooley

Following the medtech industry’s rapid rise early in the month, a plateau was inevitable, and that trend continued through the holiday week. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 98.23 (Nov. 27), marking a 0.2% uptick from the 97.99 points registered at the […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: 3m, AstraZeneca plc, Boston Scientific, butterflynetwork, coronavirus, COVID-19, MedTech 100 Index, Medtronic

HHS confirms involvement in presidential transition process

November 25, 2020 By Sean Whooley

U.S. Health and Human Services Dept. Secretary Alex Azar confirmed that HHS is working with president-elect Joe Biden on a presidential transition. Speaking during a press briefing, Azar said HHS is in contact with the transition team after the General Services Administration formally recognized Biden as the president-elect, having previously sidestepped questions regarding the potential […]

Filed Under: Featured, Legal News, Pharmaceutical Tagged With: AstraZeneca plc, BioNTech, coronavirus, COVID-19, Dept. of Health & Human Services (HHS), Joe Biden, Moderna, Pfizer

BREAKING: AstraZeneca says its COVID-19 vaccine could be up to 90% effective

November 23, 2020 By Sean Whooley

AstraZeneca (NYSE:AZN) announced today that one of its COVID-19 vaccine candidate dosing regimens is 90% effective in preventing the virus. Cambridge, United Kingdom-based AstraZeneca, working in collaboration with Oxford University, found the vaccine to be highly effective in preventing COVID-19 for subjects in the UK and Brazil, with no hospitalizations or severe cases of the disease […]

Filed Under: Clinical Trials, Featured, Pharmaceutical, Research & Development Tagged With: AstraZeneca plc, coronavirus, COVID-19, Oxford University

Report: Oxford chief says there’s ‘small chance’ COVID-19 vaccine is ready by Christmas

November 4, 2020 By Sean Whooley

The director of the group developing a COVID-19 vaccine candidate at Oxford University says it’s possible that the vaccine could be ready by Christmas. According to a Reuters report, Oxford vaccine trial chief investigator Andrew Pollard said he’s optimistic that the university, which is collaborating with AstraZeneca on the vaccine, will present trial results by the end […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Pharmaceutical, Research & Development Tagged With: AstraZeneca plc, coronavirus, COVID-19, Oxford University

Report: FDA expanding AstraZeneca vaccine probe

October 1, 2020 By Sean Whooley

The U.S. FDA is reportedly expanding its probe into a serious illness arising in the COVID-19 vaccine study from AstraZeneca (NYSE:AZN). This news, reported by Reuters, follows last week’s statement from U.S. Health and Human Services Dept. Secretary Alex Azar that federal investigators are looking for “answers to important questions,” regarding the safety of patients involved in […]

Filed Under: Clinical Trials, Featured, Pharmaceutical, Research & Development Tagged With: AstraZeneca plc, coronavirus, COVID-19, FDA

What are the top COVID-19 vaccine candidates?

September 25, 2020 By Nancy Crotti

As of yesterday, five COVID-19 vaccine candidates had begun Phase 3 clinical trials as they seek to determine the safety and efficacy of their formulas. Researchers worldwide are testing 132 COVID-19 vaccine candidates, including 42 that are in clinical trials on humans and at least 92 in preclinical or animal trials, according to the New […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Pharmaceutical, Research & Development Tagged With: AstraZeneca plc, BioNTech, coronavirus, COVID-19, GlaxoSmithKline plc, Johnson & Johnson, Moderna, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Pfizer, Sanofi, U.S. Biomedical Advanced Research and Development Authority (BARDA)

Report: AstraZeneca Phase III COVID-19 vaccine remains on hold in U.S.

September 24, 2020 By Sean Whooley

AstraZeneca (NYSE:AZN) is reportedly keeping its COVID-19 vaccine trial in the U.S. on hold as questions remain over patient safety. U.S. Health and Human Services Dept. Secretary Alex Azar told CNBC yesterday that federal investigators are looking for “answers to important questions,” regarding the safety of patients involved in the trial operated by the United Kingdom-based company in […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Pharmaceutical Tagged With: AstraZeneca plc, coronavirus, COVID-19, Dept. of Health & Human Services (HHS), Donald Trump, Oxford University

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 5
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS